{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:31Z","timestamp":1780426891402,"version":"3.54.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Project for Public Welfare Scientific Research Guidance in the Field of Agriculture and Social Development of Hangzhou Science and Technology Bureau\u00ef\u00bc\u0152","award":["No.20241029Y144"],"award-info":[{"award-number":["No.20241029Y144"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alcohol-induced liver injury remains a major public health concern, and effective hepatoprotective agents are urgently needed. Scutellarein (SCU), a natural flavonoid, has shown potential biological activity, but its hepatoprotective effects and underlying mechanisms against alcohol-induced hepatocyte injury have not been fully elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An in vitro model of alcohol-induced hepatocyte injury was established using human LO2 cells exposed to 400\u2009mM alcohol. Cells were pretreated with 5 \u00b5M SCU, and multiple assays were performed to evaluate hepatocyte viability, hepatic enzyme activity, apoptosis, inflammatory cytokine expression, oxidative stress, and related signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>SCU pretreatment effectively reversed the alcohol-induced reduction in cell viability and significantly lowered alanine aminotransferase and aspartate aminotransferase levels. SCU inhibited apoptosis by downregulating BAX and upregulating BCL2, and attenuated inflammatory responses by reducing interleukin-1\u03b2, interleukin-6, and tumor necrosis factor-alpha expression. Mechanistically, SCU suppressed nuclear factor kappa-B signaling by decreasing phosphorylation of p65 and inhibitor of nuclear factor kappa-B\u03b1. In addition, SCU enhanced antioxidant defense by upregulating superoxide dismutase 1, superoxide dismutase 2, and catalase, and activating the nuclear factor erythroid 2\u2013related factor 2\u2013NAD(P)H quinone dehydrogenase 1 pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>SCU protects hepatocytes against alcohol-induced injury by modulating apoptosis, inflammation, and oxidative stress through regulation of nuclear factor kappa-B and nuclear factor erythroid 2\u2013related factor 2 signaling pathways. These findings highlight its potential as a promising hepatoprotective agent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044506","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:01:19Z","timestamp":1759248079000},"page":"e44506","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Scutellarein attenuates alcohol-induced hepatocyte injury by modulating NF-\u03baB and NRF2 signaling pathways"],"prefix":"10.1097","volume":"104","author":[{"given":"Shuxia","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First People\u2019s Hospital of Linping District, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First People\u2019s Hospital of Linping District, Hangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-8608","authenticated-orcid":false,"given":"Ziqi","family":"Sui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.cgh.2023.02.017","article-title":"Alcohol-associated liver disease: integrated management with alcohol use disorder.","volume":"21","author":"Arab","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"e176345","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease.","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"e077090","DOI":"10.1136\/bmj-2023-077090","article-title":"Advances in the understanding and management of alcohol-related liver disease.","volume":"383","author":"Thursz","year":"2023","journal-title":"BMJ"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.3390\/ijms22105170","article-title":"Alcohol-related liver disease: basic mechanisms and clinical perspectives.","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease.","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12967-023-04166-8","article-title":"Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease.","volume":"21","author":"Yan","year":"2023","journal-title":"J Transl Med"},{"issue":"Suppl","key":"R7-20260602","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.3350\/cmh.2024.0709","article-title":"Alcohol-associated liver disease: Natural history, management and novel targeted therapies.","volume":"31","author":"Alvarado-Tapias","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease.","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40265-023-01939-9","article-title":"Alcohol-associated liver disease: evolving concepts and treatments.","volume":"83","author":"Prince","year":"2023","journal-title":"Drugs"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review.","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.3390\/ijms24043735","article-title":"Alcohol, inflammation, and microbiota in alcoholic liver disease.","volume":"24","author":"Dukic","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2741\/1765","article-title":"Apoptosis in alcoholic and nonalcoholic steatohepatitis.","volume":"10","author":"Feldstein","year":"2005","journal-title":"Front Biosci"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1530-0277.2003.tb02886.x","article-title":"Role of apoptosis in alcoholic liver injury.","volume":"27","author":"Ishii","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"116334","DOI":"10.1016\/j.bcp.2024.116334","article-title":"PSTPIP2 protects against alcoholic liver injury and invokes STAT3-mediated suppression of apoptosis.","volume":"225","author":"Yin","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"778","DOI":"10.5152\/tjg.2024.24159","article-title":"Selenium attenuates ethanol-induced hepatocellular injury by regulating ferroptosis and apoptosis.","volume":"35","author":"Chen","year":"2024","journal-title":"Turk J Gastroenterol"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3892\/mmr.2024.13208","article-title":"Food therapy of scutellarein ameliorates pirarubicin\u2011induced cardiotoxicity in rats by inhibiting apoptosis and ferroptosis through regulation of NOX2\u2011induced oxidative stress.","volume":"29","author":"Lan","year":"2024","journal-title":"Mol Med Rep"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"101352","DOI":"10.1016\/j.jcmgh.2024.04.009","article-title":"Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets.","volume":"18","author":"Feng","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"R18-20260602","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1746.2011.07003.x","article-title":"Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.","volume":"27","author":"Gao","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3892\/ijmm.2017.3015","article-title":"Therapeutic strategies for alcoholic liver disease: focusing on inflammation and fibrosis (review).","volume":"40","author":"Kawaratani","year":"2017","journal-title":"Int J Mol Med"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2017.06.007","article-title":"Targeting inflammation for the treatment of alcoholic liver disease.","volume":"180","author":"Xu","year":"2017","journal-title":"Pharmacol Ther"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"120180","DOI":"10.1016\/j.lfs.2021.120180","article-title":"Interleukin-9 attenuates inflammatory response and hepatocyte apoptosis in alcoholic liver injury.","volume":"288","author":"Meng","year":"2022","journal-title":"Life Sci"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13046-020-01782-w","article-title":"Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARalpha to activate the NF-kappaB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.","volume":"40","author":"Kong","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/JIR.S341680","article-title":"CD73 attenuates alcohol-induced liver injury and inflammation via blocking TLR4\/MyD88\/NF-kappaB signaling pathway.","volume":"15","author":"Liu","year":"2022","journal-title":"J Inflamm Res"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3390\/molecules27123782","article-title":"Scutellarein inhibits LPS-induced inflammation through NF-kappaB\/MAPKs signaling pathway in RAW264.7 cells.","volume":"27","author":"Park","year":"2022","journal-title":"Molecules"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/ptr.8232","article-title":"Scutellarein alleviates osteoarthritis progression through the PI3K\/Akt\/NF-kappaB signaling pathway: in vitro and in vivo studies.","volume":"38","author":"Ye","year":"2024","journal-title":"Phytother Res"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/antiox13060710","article-title":"Scutellarein suppresses the production of ROS and inflammatory mediators of LPS-activated bronchial epithelial cells and attenuates acute lung injury in mice.","volume":"13","author":"Li","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"Pt 3","key":"R27-20260602","doi-asserted-by":"crossref","first-page":"134809","DOI":"10.1016\/j.ijbiomac.2024.134809","article-title":"Oxidative stress in alcoholic liver disease, focusing on proteins, nucleic acids, and lipids: a review.","volume":"278","author":"Lai","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0029-1214370","article-title":"Oxidative stress and alcoholic liver disease.","volume":"29","author":"Wu","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"11 Suppl","key":"R29-20260602","first-page":"110S","article-title":"Oxidative stress and signal transduction pathways in alcoholic liver disease.","volume":"29","author":"Zima","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"747325","DOI":"10.3389\/fphar.2021.747325","article-title":"Kinsenoside alleviates alcoholic liver injury by reducing oxidative stress, inhibiting endoplasmic reticulum stress, and regulating AMPK-dependent autophagy.","volume":"12","author":"Gao","year":"2021","journal-title":"Front Pharmacol"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.1021\/acs.jafc.4c04762","article-title":"Ursolic acid ameliorates alcoholic liver injury through attenuating oxidative stress-mediated ferroptosis and modulating gut microbiota.","volume":"72","author":"Zhou","year":"2024","journal-title":"J Agric Food Chem"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"156125","DOI":"10.1016\/j.phymed.2024.156125","article-title":"Qiwei Jinggan Ling regulates oxidative stress and lipid metabolism in alcoholic liver disease by activating AMPK.","volume":"135","author":"Wan","year":"2024","journal-title":"Phytomedicine"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jare.2024.01.030","article-title":"Simultaneous binding of quercetin and catechin to FOXO3 enhances IKKalpha transcription inhibition and suppression of oxidative stress-induced acute alcoholic liver injury in rats.","volume":"67","author":"Guan","year":"2025","journal-title":"J Adv Res"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"105207","DOI":"10.1016\/j.fitote.2022.105207","article-title":"Synthesis and biological evaluation of scutellarein derivatives as neuroprotective agents via activating Nrf2\/HO-1 pathway.","volume":"160","author":"Han","year":"2022","journal-title":"Fitoterapia"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"8811021","DOI":"10.1155\/2020\/8811021","article-title":"Scutellarein aggravated carbon tetrachloride-induced chronic liver injury in gut microbiota-dysbiosis mice.","volume":"2020","author":"Miao","year":"2020","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:01Z","timestamp":1780423321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":35,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044506","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-05-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}